Reventós J

No ORCID on file · 2 papers in corpus · active 2017-2022
2022
Journal of personalized medicine ·doi:10.3390/jpm12071074

Screenwide is a case-control study (2017−2021) including women with incident endometrial and ovarian cancers (EC and OC), BRCA1/2 and MMR pathogenic variant carriers, and age-matched controls from three centers in Spain. Participants comple…

2017
Autophagy ·doi:10.1080/15548627.2016.1271512

Targeted therapies in endometrial cancer (EC) using kinase inhibitors rarely result in complete tumor remission and are frequently challenged by the appearance of refractory cell clones, eventually resulting in disease relapse. Dissecting a…